Both in Pharmaceuticals
Propanc Biopharma vs Ernexa Therapeutics
Over the past year PPCB returned −99.3% and ERNA returned −95.3%; their daily moves had a correlation of 0.06.
PPCB −99.3% ERNA −95.3%Growth of $1, one year, split-adjusted
| Metric | PPCB | ERNA |
|---|---|---|
| Price | $1.79 | $1.99 |
| Market cap | $1.8M | $2.3M |
| Today | +4.68% | −1.49% |
| 1 month | −63.6% | −11.0% |
| 6 months | −92.9% | −67.1% |
| Year to date | −98.7% | −93.4% |
| 1 year | −99.4% | −95.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $832.0K | $5.0M |
| Dividend yield | — | — |
| Volatility (60d) | 730.0% | 78.2% |
| Short % of float | 0.7% | 2.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).